|
Drug Treatment for Pathologic Gambling Disorder Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Drug Treatment for Pathologic Gambling Disorder conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Drug Treatment for Pathologic Gambling Disorder Clinical research trials and Drug Treatment for Pathologic Gambling Disorder healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Drug Treatment for Pathologic Gambling Disorder. Drug Treatment for Pathologic Gambling Disorder Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Drug Treatment for Pathologic Gambling Disorder clinical trial. Participants typically obtain the most effective healthcare available for their Drug Treatment for Pathologic Gambling Disorder condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Drug Treatment for Pathologic Gambling Disorder  Drug Treatment for Pathologic Gambling Disorder
Drug Treatment for Pathologic Gambling Disorder
For Condition: Impulse Control Disorders
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to establish the best dose of the drug naltrexone for patients with Pathological Gambling Disorder (PGD) and severe urge symptoms.
Details: PGD is a prominent and growing social problem. Unfortunately, there is no established drug treatment for this disorder. Preliminary investigations demonstrate that naltrexone in doses up to 250 mg/day is well tolerated and safe during an 11-week period and may be a viable treatment option for PGD patients with severe urges. The implications of this study extend from PGD to other impulse control disorders, including compulsive shopping, kleptomania, and possibly alcoholism. Participants are randomly assigned to receive either naltrexone or placebo for 16 weeks. The responses of men and women are compared to determine whether efficacy is distributed in a male:female ratio analogous to that of the PGD population in the United States. A Clinical Global Impression and a Gambling Symptom Scale are used to assess participants.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 21 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - DSM-IV criteria for Pathological Gambling Disorder - Moderate or severe gambling urge assessed by the Gambling Symptom Assessment Scale - No psychiatric drug use for 2 weeks or more - Score >= 5 on The South Oaks Gambling Screen - Hamilton Depression Rating Scale and Anxiety Rating score < 26. An increase (up to 10 points) of the scores is allowed unless the subject shows the risks of suicide. - Completion of complete blood count, urinalysis, liver and thyroid function tests, and pregnancy tests, with no evidence of significant lab abnormalities - Reliable birth control in women of child-bearing potential
Total Enrollment: 156
Location and Contact Information:
Overall Study Official:
SuckKim, Principal Investigator, University of Minnesota
University of Minnesota Medical School *Recruiting*
Minneapolis, Minnesota, 55454
United States
Recruiting Suck Kim 612-273-9805
Additional Information:
Study ID Numbers: 65920-01;
Study Start Date: December 2002
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00053677
Other Impulse Control Disorders Studies:
1. Drug Treatment for Pathologic Gambling Disorder
Related Studies:
Other Impulse Control Disorders Clinical Trials
Other Minnesota Clinical Trials
Other Minneapolis Clinical Trials
Drug Treatment for Pathologic Gambling Disorder
|
|
|
|
|
|
|
|
